February 4, 2012
Pharmacy news, jobs, continuing education, community and more.
INDIANAPOLIS – Eli Lilly and Company (NYSE:LLY) today announced that the U.S. Court of Appeals for the Federal Circuit has overturned a prior ruling by the U.S. District Court for the District of New Jersey and has upheld the validity of the company’s method-of-use patent on Strattera® (atomoxetine). In the case of Eli Lilly and [...]
INDIANAPOLIS, Aug 12, 2010 -Eli Lilly and Company (NYSE: LLY) today announced that the U.S. District Court for the District of New Jersey has ruled against the company in its patent litigation for Strattera(R) (atomoxetine). In the case of Eli Lilly and Company v. Actavis Elizabeth LLC, et al, the court ruled that Lilly’s ’590 [...]
© Rx Times, LLC 2011. All rights reserved. All products denoted with ™ and ® are trademarks or registered trademarks of Rx Times, LLC and/or its affiliates.